The transaction will increase the company's retail footprint to 118 dispensaries across the country.

The new line, which will be made with Curaleaf's Select brand, will include the first-ever Select pre-roll and "The Cliq," a proprietary pod system.

Senior Vice President of Operations, Ashley Beal, spoke with New Cannabis Ventures about CapStone’s investment approach, its cannabis investments and how the small but mighty team is more than just a resource of capital funds.

U.S. cannabis company Curaleaf agreed to acquire London-based Emmac Life Sciences in a $286 million deal that represents the company’s first step into the burgeoning European cannabis market.

Curaleaf Holdings Inc. agreed to buy Emmac Life Sciences Ltd. for about $285 million, giving the company entry into Europe’s rapidly growing cannabis market.

Curaleaf chairman Boris Jordan is dropping industry insights you won’t find anywhere else, including why a huge regulatory catalyst could be coming within the next six months.

The largest marijuana company in America is on a mission to convert non-consumers into customers by selling them highly formulated products.

Curaleaf stock is already up more than 41% this year, but three main factors could give the Massachusetts company an even bigger boost.

The company's last quarter was a good one, even with the effects of COVID-19 in some of its markets.

Curaleaf reshaped its operations to meet customer needs in places where cannabis retailers were labeled “essential” at peak lockdown.

The recent purchase of the Chicago cannabis retailer Grassroots makes Curaleaf the biggest cannabis company globally by sales, with expected annual revenue of about $1 billion.

The cannabis producer, which today completed its purchase of GR Companies Inc., saw its highest-ever monthly sales in June, Boris Jordan said in an interview.

CapStone Holdings Inc. said Monday it has decided to take a stake in the cannabis industry by investing $50 million in Curaleaf Holdings Inc

Curaleaf is a leading U.S. provider of cannabis-based medical and adult-use products.